FDA Slaps Black Box Warning On Plavix

Law360, New York (March 15, 2010, 4:32 PM EDT) -- The U.S. Food and Drug Administration has added a black box warning to the packaging of Plavix, saying between 2 and 14 percent of the U.S. population cannot properly metabolize the blood-thinning drug and do not benefit from its use.

The heightened warning, announced Friday, comes more than a year after the agency said it was working with the drug's makers, Sanofi-Aventis SA and Bristol-Myers Squibb Co., to examine the impact of genetic factors on its efficacy.

The companies said Friday that approximately 2 percent of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.